Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Lannett Company, Inc.

NYSE: LCIHealthcare / Drugs - Generic / USA
7.53-0.2500-3.21%Vol 1 530 4861Y Perf -69.30%
Jan 16th, 2019 16:00
BID7.01 ASK7.73
Open7.79 Previous Close7.78
Pre-Market- After-Trading7.53
 - -%  - -%
Target Price
8.00 
Analyst Rating
Hold 3.00
Potencial %
6.24 
Finscreener Ranking
★★+     47.97
Insiders Trans % 3/6/12M
100/100/67 
Value Ranking
★★     46.83
Insiders Value % 3/6/12M
100/100/39 
Growth Ranking
+     28.12
Insiders Shares Cnt. % 3/6/12M
100/100/66 
Income Ranking
 —    -
Market Cap (mil)296 
Earnings Rating
Sell
Price Range Ratio 52wk %
19.36 
Earnings Date
6th Feb 2019

Today's Price Range

7.127.89

52wk Range

3.3325.02

5 Year PE Ratio Range

4.20111.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
65.13%
3 Months
82.32%
6 Months
-42.74%
1 Year
-69.30%
3 Years
-77.93%
5 Years
-79.05%

Quotes

Name / TickerPriceChg.Chg.%
LCI7.53-0.2500-3.21
AAPL154.941.87001.22
GOOG1 080.973.82000.35
MSFT105.380.37000.35
XOM71.64-0.0300-0.04
WFC48.941.27002.66
JNJ128.04-1.3200-1.02
FB147.54-1.4100-0.95
GE8.980.25002.86
JPM102.500.82000.81
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.90
Current Ratio
2.90
Long Term Debt to Total Capital
0.71
Total Debt to Equity
2.65
Interest Coverage
-2.90
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
40.90
EBIT Margin
-36.00
EBITDA Margin
-27.80
Pre-tax Profit Margin
21.60
Profit Margin
-57.18
ValuationValueIndustryS&P 500US Markets
PE Ratio
7.10
PB Ratio
0.98
PS Ratios
0.61
Price to Cash Flow
1.70
Price to Free Cash Flow
6.30
Cash Flow Per Share
4.59
Price to Tangible Book
-2.93
Book Value per Share
7.95
Enterprise Value (in ths.)
981 763
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
12.51
ROE last 12 Months
-61.26
Return on Assets (5Y Avg)
3.90
ROA last 12 Months
-18.94
Return on Capital (5Y Avg)
16.90
ROC last 12 Months
-15.45
Return on invested Capital Q
-20.95
Return on invested Capital Y
6.28
Assets Turnover
0.10
Receivables Turnover
0.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
500 351
Revenue per Share
12.74
Revenue Growth 3 Years
10.08
Revenue Growth 5 Years
25.44
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q01 20190.400.4410.00
Q04 20180.640.640.00
Q03 20180.760.805.26
Q02 20180.861.0623.26
Q01 20180.520.6015.38
Q04 20170.400.400.00
Q03 20170.870.77-11.49
Q02 20170.830.9210.84
Earnings Per EndEstimateRevision %Trend
12/2018 QR0.68-10.53Negative
3/2019 QR0.762.70Positive
6/2019 FY2.09-0.48Negative
6/2020 FY0.97-8.49Negative
Next Report Date6th Feb 2019
Estimated EPS Next Report0.68
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 530 486
Shares Outstanding (in ths.)39 270
Trades Count5 019
Dollar Volume10 546 602
Avg. Volume2 019 684
Avg. Weekly Volume1 220 465
Avg. Monthly Volume1 597 146
Avg. Quarterly Volume1 696 418

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

53%47%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News